Tmc1-KO 基因敲除小鼠

1. Marcovich, Irina, Baer, Nicholas K, Shubina-Oleinik, Olga, Beard, Clayton W, Holt, Jeffrey R. 2022. Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11. In Biomolecules, 12, . doi:10.3390/biom12070914. https://pubmed.ncbi.nlm.nih.gov/35883470/

2. Wu, Jason, Solanes, Paola, Nist-Lund, Carl, Schneider, Bernard L, Holt, Jeffrey R. 2020. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice. In Molecular therapy : the journal of the American Society of Gene Therapy, 29, 973-988. doi:10.1016/j.ymthe.2020.11.016. https://pubmed.ncbi.nlm.nih.gov/33212302/

3. Del Castillo, Ignacio, Morín, Matías, Domínguez-Ruiz, María, Moreno-Pelayo, Miguel A. 2022. Genetic etiology of non-syndromic hearing loss in Europe. In Human genetics, 141, 683-696. doi:10.1007/s00439-021-02425-6. https://pubmed.ncbi.nlm.nih.gov/35044523/

4. Ma, Jing, Ma, Xiuli, Lin, Ken, Gao, Yingqin, Zhang, Tiesong. 2023. Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel. In Human genomics, 17, 1. doi:10.1186/s40246-022-00449-1. https://pubmed.ncbi.nlm.nih.gov/36597107/

5. Boucher, Sophie, Tai, Fabienne Wong Jun, Delmaghani, Sedigheh, Bonnet, Crystel, Petit, Christine. 2020. Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis. In Proceedings of the National Academy of Sciences of the United States of America, 117, 31278-31289. doi:10.1073/pnas.2010782117. https://pubmed.ncbi.nlm.nih.gov/33229591/